Global Health Now featured a commentary, authored by GHTC Director Jamie Bay Nishi, highlighting key findings from GHTC's report Pain Points and Potential: How COVID-19 is Reshaping Global Health R&D.
Devex cited a report released by GHTC assessing the impact of the COVID-19 pandemic on global health R&D.
Health Europa covered a report released by GHTC assessing the impact of the COVID-19 pandemic on global health R&D.
ScienceBoard.net, a publication covering life science and pharmaceutical trends, reported on a findings from GHTC's report, Pain Points and Potential: How COVID-19 is Reshaping Global Health R&D.